TxA2-mediated myocardial ischemia as a consequence of an acute lung inflammatory reaction in the rabbit

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 2, 2003, Pages 314-319

  Evangelista, V ^a   Dell'elba, G ^a   Celardo, A ^a   Manarini, S ^a   Cerletti, C ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Inflammation; Lung; Myocardial ischemia; Thromboxane A2

Indexed keywords

AUTACOID; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PROSTACYCLIN; THROMBOXANE A2;

ACUTE DISEASE; ANIMAL; ARTERIOSCLEROSIS; ARTICLE; BLOOD; DISEASE MODEL; ELECTROCARDIOGRAPHY; HEART MUSCLE ISCHEMIA; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PNEUMONIA; RABBIT; THROMBOCYTE ACTIVATION;

ACUTE DISEASE; ANIMALS; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; EPOPROSTENOL; INFLAMMATION MEDIATORS; MALE; MYOCARDIAL ISCHEMIA; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PLATELET ACTIVATION; PNEUMONIA; RABBITS; THROMBOXANE A2;

EID: 0141673320     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00067.x     Document Type: Article

References (30)

1. Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. N Engl J Med 1997; 336: 1014-6.
2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
3. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92.
4. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
5. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
6. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 1997; 349: 1391-2.
7. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratorytract infections and risk of first-time acute myocardial infarction. Lancet 1998; 351: 1467-71.
8. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990; 81: 1983-91.
9. Michelassi F, Landa L, Hill RD, Lowenstein E,Watkins WD, Petkau AJ, Zapol WM. Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science 1982; 217: 841-3.
10. Bittl JA, Pfeffer MA, Lewis RA, Mehrotra MM, Corey EJ, Austen KF. Mechanism of the negative inotropic action of leukotrienes C4 and D4 on isolated rat heart. Cardiovasc Res 1985; 19: 426-32.
11. Nichols WW, Mehta JL, Thompson L, Donnelly WH. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function. Am J Physiol 1988; 255: H153-H159.
12. Lopez JA, Armstrong ML, Piegors DJ, Heistad DD. Effect of early and advanced atherosclerosis on vascular responses to serotonin, thromboxane A2, and ADP. Circulation 1989; 79: 698-705.
13. Evangelista V, Celardo A, Dell'Elba G, Manarini S, Mironov A, de Gaetano G, Cerletti C. Platelet contribution to leukotriene production in inflammation: in vivo evidence in the rabbit. Thromb Haemost 1999; 81: 442-8.
14. Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemost 1987; 58: 1078-84.
15. Celardo A, Dell'Elba G, Eltantawy ZM, Evangelista V, Cerletti C. Simultaneous determination of leukotrienes B4 and E4 in whole blood and of leukotriene E4 in urine of rabbit by reversed-phase highperformance liquid chromatography. J Chromatogr B Biomed Appl 1994; 658: 261-9.
16. Celardo A, Dell'Elba G, Manarini S, Evangelista V, de Gaetano G, Cerletti C. Kinetics of endogenous leukotriene B4 and E4 production following injection of the chemotactic peptide FMLP in the rabbit. Prostaglandins 1997; 54: 699-711.
17. Davì G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G, Patrono C. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. New Engl J Med 1990; 322: 1769-74.
18. Theroux P, Willerson JT, Armstrong PW. Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000). Circulation 2000; 102: IV2-IV13.
19. Gillespie MN, Booth DC, Friedman BJ, Cunningham MR, Jay M, DeMaria AN. fMLP provokes coronary vasoconstriction and myocardial ischemia in rabbits. Am J Physiol 1988; 254: H481-H486.
20. Tippins JR, Antoniw JW, Alison MR, Garvey B, Maseri A. WEB 2086 inhibits neutrophil dependent increases in coronary resistance in blood perfused rabbit heart. Cardiovasc Res 1992; 26: 162-9.
21. Rossoni G, Sala A, Berti F, Testa T, Buccellati C, Molta C, Muller-Peddinghaus R, Maclouf J, Folco GC. Myocardial protection by the leukotriene synthesis inhibitor BAY X1005. Importance of transcellular biosynthesis of cysteinyl-leukotrienes. J Pharmacol Exp Ther 1996; 276: 335-41.
22. Sala A, Rossoni G, Berti F, Buccellati C, Bonazzi A, Maclouf J, Folco G. Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness. Circulation 2000; 101: 1436-40.
23. Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung. J Pharmacol Exp Ther 1992; 260: 832-40.
24. Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest 1980; 66: 979-86.
25. FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ 2nd, Lawson JA, Brash AR. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983; 71: 676-88.
26. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, Fitzgerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002; 296: 539-41.
27. Evers AS, Murphree S, Saffitz JE, Jakschik BA, Needleman P. Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest 1985; 75: 992-9.
28. Carvalho ACA, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974; 290: 434-8.
29. Tremoli E, Folco G, Agradi E, Galli C. Platelet thromboxanes and serum-cholesterol. Lancet 1979; 1: 107-8.
30. Luscher TF, Noll G. Is it all in the genes? Nitric oxide synthase and coronary vasospasm. Circulation 1999; 99: 2855-7.